OOIR: Observatory of International Research

Papers

(The H4-Index of BMC Cancer is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up	165
The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma	162
Clinical benefits of enhanced 3D-NEVERview sequence in MRI simulation for nasopharyngeal carcinoma patients received radiotherapy	86
The mortality rate of people with cancer judged to have a limited life expectancy by physicians performing work disability assessments in the Netherlands: a retrospective cohort study	79
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis	73
Prospective clinical evidence from over 1,000 pan-cancer patients: a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting	70
Analysis of characteristics of peripheral blood lymphocytes in endometrial carcinoma: a single-center study based on five-year clinical data	70
Ten-year follow-up of atypical small acinar hyperplasia cases diagnosed by initial prostate biopsy	69
Targeting INF2 with DiosMetin 7-O-β-D-Glucuronide: a new stratagem for colorectal cancer therapy	67
Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0–4): study protocol for a prospective, multicentre, random	67
Association between preoperative anxiety states and postoperative complications in patients with esophageal cancer and COPD: a retrospective cohort study	66
“It's very important that you measure throughout that journey…”: patient perspectives towards quality-of-life data collection following haematopoietic cell transplant	66
Dynamic CEA kinetics as a prognostic biomarker for HER2-negative advanced gastric cancer treated with chemoimmunotherapy	66
Safety and feasibility of liver resection including major hepatectomy for geriatric patients with hepatocellular carcinoma: a retrospective observational study	64
α-L-fucosidase isoenzymes (FUCA1/FUCA2) as prognostic markers in gliomas: a comprehensive study	64
Assessing the performance of QLQ-C30 in predicting all-cause mortality in community cancer patients	64
Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study	63
Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantation	63
Innovative inhalable dry powder: nanoparticles loaded with Crizotinib for targeted lung cancer therapy	62
MTF1 genetic variants are associated with lung cancer risk in the Chinese Han population	62
Impact of lenalidomide consolidation on health-related quality of life in chronic lymphocytic leukemia: ancillary study of the phase III CLL6-RESIDUUM trial	60
High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis	60
Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy	59
Adipogenesis biomarkers as the independent predictive factors for breast cancer recurrence: a systematic review and meta-analysis	58
Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis	57

Short-term impact of delayed surgical treatment on the prognosis of patients with T1bN1-stage PTC: a retrospective cohort study	57
Reappraisal of the prognostic significance of vaginal invasion, parametrial invasion and lymph node metastasis in locally advanced cervical cancer patients receiving concurrent chemoradiotherapy: a mu	56
Tumor-Infiltrating lymphocyte dynamics as biomarkers of neoadjuvant treatment response in luminal breast cancer	56
Hsa_circ_0004872 alleviates meningioma progression by sponging miR-190a-3p/PTEN signaling	55
Cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production	55
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study	54
Mismatch repair, p53, and L1 cell adhesion molecule status influence the response to chemotherapy in advanced and recurrent endometrial cancer	54
Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experience	53
The effects of daratumumab on bone disease in patients with newly diagnosed multiple myeloma: a multi-center retrospective study	53
Network Evolution Model-based prediction of tumor mutation burden from radiomic-clinical features in endometrial cancers	53
Factors influencing clinical decision-making and health-related quality of life changes in colorectal cancer patients receiving targeted therapy: a multicenter study in China	52
Gene mutation in cancer patients with diabetes: a real-world retrospective cohort study	52
Exploring the role of ELOVLs family in lung adenocarcinoma based on bioinformatic analysis and experimental validation	52
Deep learning-based characterization of pathological subtypes in lung invasive adenocarcinoma utilizing 18F-deoxyglucose positron emission tomography imaging	51
Antibiotic use during radical surgery in stage I-III colorectal cancer: correlation with outcomes?	50
Factors associated with skin exposure of central venous ports in patients undergoing chemotherapy: a retrospective study	50
Correction to: Early-stage hodgkin lymphoma in Cape Town, South Africa: prognostic risk factors at diagnosis and treatment outcomes	50
Effective serum concentration of high-dose methotrexate therapy for osteosarcoma with dose adjustment for pharmacokinetic parameters: a retrospective study	49
Changing patterns of nasopharyngeal carcinoma incidence in Hong Kong: a 30-year analysis and future projections	49
Genomic characterization of colorectal tumors: insights into significantly mutated genes, pathways, and survival outcomes	48
The effect of exercise intervention on IGF axis and metabolic markers regulation in breast cancer patients: a systematic review with pairwise, network, and dose-response meta-analyses	48
microRNA-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation	48
Oral cavity and oropharyngeal carcinoma disparities in age and survival in Indigenous and non-Indigenous populations of Queensland	48